Bringing you the latest cutting-edge research and commentary in bioscience.

Cell & Gene Therapy Insights

Cell & Gene Therapy Insights

Expert Insight
Spotlight Article

Innovating CAR T cell therapy for today and tomorrow

Immuno-oncology: manufacturing and commercial business models for the new decade

David Chang, MD, PhD

A new era has emerged in the cancer treatment landscape as cell therapies demonstrate their potential to be game changing. Inherent limitations of autologous CAR T cell therapies exist, which can restrict their application. There-fore, further exploration into engineered allogeneic CAR T cell therapy is needed as early research in hematologic cancers has demonstrated the potential of this powerful immunotherapy.

DOI: 10.18609/cgti.2020.090
Citation: Cell & Gene Therapy Insights 2020; 6(6), 783–788
Open access
This content is restricted to registered users. Click here to Register or Login here.
Twitter IconVisit Our Blog